La chaîne d'options affiche les données clés des options sur actions de Aquaron Acquisition Corp. - Rights à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Aquaron Acquisition Corp. - Rights..

Aquaron Acquisition Corp. - Rights (NASDAQ:AQUNR) Stock, Chaîne d'Options

Aquaron Acquisition Corp. - Rights

Keybanc analyst Brandon Nispel maintains Cable One (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CABO#NYSE">CABO</a>) with a Overweight and lowers the price target from $825 to $650.

News

Price Target

Analyst Ratings

CABO

Keybanc Maintains Overweight on Cable One, Lowers Price Target to $650

WIIM

DCBO

Docebo shares are trading lower after the company issued Q1 revenue guidance below estimates.

Keybanc analyst Noah Zatzkin maintains Acushnet Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOLF#NYSE">GOLF</a>) with a Overweight and lowers the price target from $80 to $77.

GOLF

Keybanc Maintains Overweight on Acushnet Hldgs, Lowers Price Target to $77

AKAM

Akamai Technologies shares are trading higher after the company disclosed that its CEO made a $3 million purchase in common stock.

ASTH

Astrana Health shares are trading lower after the company reported worse-than-expected Q4 EPS results.

Keybanc analyst Michael Leshock maintains Rocket Lab USA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) with a Overweight and lowers the price target from $32 to $28.

RKLB

Keybanc Maintains Overweight on Rocket Lab USA, Lowers Price Target to $28

CORRECTION: Piper Sandler analyst Derek Podhaizer maintains TechnipFMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTI#NYSE">FTI</a>) with a Overweight and raises the price target from $39 to $40 - Analyst Name Updated.

CORRECTION: Piper Sandler Maintains Overweight on TechnipFMC, Raises Price Target to $40 (Analyst Name Updated)

CAVA

Cava Group shares are trading higher after Piper Sandler upgraded its rating on the stock from neutral to overweight despite lowering its price target from $142 to $115.

Chardan Capital analyst Keay Nakae maintains Dyne Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYN#NASDAQ">DYN</a>) with a Buy and maintains $50 price target.

Chardan Capital Maintains Buy on Dyne Therapeutics, Maintains $50 Price Target

ADSK

Autodesk shares are trading lower after Baird cut its price target on the stock from $345 to $336.

Stephens &amp; Co. analyst Jeff Lick upgrades Openlane (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KAR#NYSE">KAR</a>) from Equal-Weight to Overweight and raises the price target from $20 to $26.

Upgrades

Stephens & Co. Upgrades Openlane to Overweight, Raises Price Target to $26

EOG Resources shares are trading lower. The company reported Q4 financial results.

Chardan Capital analyst Geulah Livshits maintains Rocket Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCKT#NASDAQ">RCKT</a>) with a Buy and lowers the price target from $62 to $54.

RCKT

Chardan Capital Maintains Buy on Rocket Pharmaceuticals, Lowers Price Target to $54

Edison International shares are trading higher after the company reported a Q4 sales and revenue beat. Also, the company raised its dividend from $0.78 to $0.8275.

Bath &amp; Body Works Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBWI#NYSE">BBWI</a>) shares rose slightly in early trading on Friday, after the company reported <a href="https://www.benzinga.com/news/earnings/25/02/43991325/salesforce-shares-sink-after-q4-revenues-miss-estimates-weak-fy26-guidance-details">its fourth-quarter results</a>.
The results came in amid an <a href="https://www.benzinga.com/earnings">exciting earnings season</a>. Here are some key analyst takeaways.
<h1 class="wp-block-heading">JPMorgan On Bath &amp; Body Works</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/586bcbd9351b9b0001ab738c/matthew-boss">Analyst Matthew Boss</a> maintained an Overweight rating and price target of $47.
Bath &amp; Body Works reported fourth-quarter earnings of $2.09 per share, beating consensus of $2.04 per share, Boss said in a note. Although revenues declined by 4.3% year-on-year, the results were better than the 4.7% decline feared, he added.
Underlying revenues, excluding the 53rd week and shortened holiday calendar, grew 2%, accelerating sequentially from 1% in the previous quarter, the analyst stated. Management guided to full-year earnings of $3.25-$3.60 per share, with the midpoint being 6% below Street expectations of $3.63 per share, with assumptions of "a more aggressive competitive and promotional backdrop Y/Y," he further wrote.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
<h1 class="wp-block-heading">Telsey Advisory Group On Bath &amp; Body Works</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/589dc33d43eaaa000122c591/jake-bartlett">Analyst Dana Telsey</a> reiterated an Outperform rating and price target of $43.
Bath &amp; Body Works delivered an earnings beat driven by a lower-than-expected decline in revenues and gross margin expansion, Telsey said. Management cited "product innovation, execution, and the customer experience" for the company's better-than-expected performance in the fourth quarter, she added.
The earnings guidance "appears prudently conservative," as it reflects the impact of U.S. tariffs on China and continued macro uncertainty, the analyst stated. "We continue to see BBWI as an established brand with a loyal customer base within an attractive consumer space characterized by strong purchase frequency of a consumable category," she further wrote.
BBW Price Action: Shares of Bath &amp; Body Works had risen by 1.98% to $36.57 at the time of publication on Friday.
Read More: <a href="https://www.benzinga.com/general/market-summary/25/02/43875446/walmarts-ai-use-cases-surge-amid-strong-q4-even-as-company-forecasts-weaker-2026">&nbsp;</a> • <a href="https://www.benzinga.com/general/market-summary/25/02/43875446/walmarts-ai-use-cases-surge-amid-strong-q4-even-as-company-forecasts-weaker-2026">Bath &amp; Body Works: New Disney Collaboration Offers Top- And Bottom-Line Inflection Opportunity: Analyst</a>
Photo: Shutterstock

Analyst Color

Earnings Beats

Reiteration

BBWI

Bath & Body Works Beats Q4, Guidance Disappoints: Analyst Says 2025 Performance Vulnerable To China Tariffs

Stephens &amp; Co. analyst Scott Fidel maintains Universal Health Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) with a Equal-Weight and raises the price target from $210 to $223.

Stephens & Co. Maintains Equal-Weight on Universal Health Servs, Raises Price Target to $223

Chardan Capital analyst Geulah Livshits maintains Intellia Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTLA#NASDAQ">NTLA</a>) with a Buy and lowers the price target from $91 to $68.

NTLA

Chardan Capital Maintains Buy on Intellia Therapeutics, Lowers Price Target to $68

Pembina Pipeline shares are trading higher after the company reported better-than-expected Q4 financial results.

Macro Economic Events

Economics

SPDR Dow Jones Industrial Average ETF Trust

Indexes are higher following in-line January PCE price index data. Markets may also be rebounding after falling this week amid a drop in chip stocks.

Deep-pocketed investors have adopted a bearish approach towards Shopify (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in SHOP usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Shopify. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 22% leaning bullish and 55% bearish. Among these notable options, 6 are puts, totaling $763,395, and 3 are calls, amounting to $99,480.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $65.0 to $114.0 for Shopify over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Shopify's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Shopify's substantial trades, within a strike price spectrum from $65.0 to $114.0 over the preceding 30 days.
<h3>Shopify 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740755758_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SHOP</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$15.95</td>
<td>$15.55</td>
<td>$15.6</td>
<td>$110.00</td>
<td>$468.0K</td>
<td>342</td>
<td align="right">300</td>
</tr>
<tr>
<td>SHOP</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/28/25</td>
<td>$5.35</td>
<td>$4.65</td>
<td>$5.1</td>
<td>$114.00</td>
<td>$124.9K</td>
<td>1.0K</td>
<td align="right">246</td>
</tr>
<tr>
<td>SHOP</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/14/25</td>
<td>$5.4</td>
<td>$5.3</td>
<td>$5.4</td>
<td>$110.00</td>
<td>$54.0K</td>
<td>95</td>
<td align="right">103</td>
</tr>
<tr>
<td>SHOP</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/28/25</td>
<td>$5.45</td>
<td>$5.2</td>
<td>$5.2</td>
<td>$113.00</td>
<td>$52.0K</td>
<td>283</td>
<td align="right">8</td>
</tr>
<tr>
<td>SHOP</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$44.5</td>
<td>$43.25</td>
<td>$43.88</td>
<td>$65.00</td>
<td>$43.8K</td>
<td>850</td>
<td align="right">0</td>
</tr>
</tbody>
</table>

<h3>About Shopify</h3>
Shopify offers an e-commerce platform primarily to small and medium-size businesses. The firm has two segments. The subscription solutions segment allows Shopify merchants to conduct e-commerce on a variety of platforms, including the company's website, physical stores, pop-up stores, kiosks, social networks (Facebook), and Amazon. The merchant solutions segment offers add-on products for the platform that facilitate e-commerce and include Shopify Payments, Shopify Shipping, and Shopify Capital.
Following our analysis of the options activities associated with Shopify, we pivot to a closer look at the company's own performance.
<h3>Shopify's Current Market Status</h3>
<ul>
<li>With a trading volume of 962,383, the price of SHOP is down by -1.96%, reaching $108.66.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 68 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Shopify</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $141.8.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from UBS has decided to maintain their Neutral rating on Shopify, which currently sits at a price target of $125. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Overweight rating on Shopify, which currently sits at a price target of $144. 
&#x2A; An analyst from Oppenheimer has decided to maintain their Outperform rating on Shopify, which currently sits at a price target of $150. 
&#x2A; An analyst from Canaccord Genuity has decided to maintain their Buy rating on Shopify, which currently sits at a price target of $140. 
&#x2A; Maintaining their stance, an analyst from Goldman Sachs continues to hold a Buy rating for Shopify, targeting a price of $150. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Shopify options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Comments

Aquaron Acquisition Corp. - Rights

Aquaron Acquisition Corp. - Rights (AQUNR) Options

No option chain data available. Please try again later

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL